Summary
- A structured self-assessment can make institutional gaps discussable. It cannot, by itself, assign an owner, approve a budget, implement a change or prove that practice improved.
- WHO describes BRIET as voluntary, capacity-strengthening and locally stored. Its current rollout supports a story about assessment and implementation pilots—not a finding that risks have already fallen.
- The useful accountability unit is a privacy-safe chain: identified gap, authorized decision, responsible owner and resources, follow-up date, and evidence of what changed.
A tool can make a problem legible
Governance often fails quietly, between a principle and the person expected to act on it. An institution may have a policy, training and a formal committee, yet still be unsure who can resolve an overlap, fund a corrective step or check whether it worked. A self-assessment can bring such questions into one frame. That is valuable—but it is a beginning, not a verdict.
The World Health Organization’s Global guidance framework for the responsible use of the life sciences, released in 2022, is intended to help Member States and other stakeholders shape policy and practice across the research life cycle. It covers laboratory biosafety, laboratory biosecurity and oversight of dual-use research. WHO presents it as adaptable guidance, with principles, tools and a staged approach—not as a binding global rule or a universal certification scheme.
On 28 August 2026, WHO launched the Biorisk Implementation and Evaluation Tool, or BRIET. WHO describes it as a voluntary structured self-assessment and capacity-strengthening tool for countries, ministries and other interested users. It can help users identify strengths and gaps, prioritize actions, receive tailored recommendations and track progress. Data generated through the tool remain stored locally on users’ systems, according to WHO. BRIET is meant to complement—not replace—the International Health Regulations monitoring tools, including the Joint External Evaluation and State Party Self-Assessment Annual Reporting tools.
Those details set the boundary for claims. BRIET is not described as inspection, certification, legal compliance testing or an independent audit. A completed questionnaire is evidence that an assessment took place. A recommendation is not evidence that an authority accepted it. An action plan is not evidence that resources were released or steps completed. A completed step is not yet evidence of changed conditions.
The distance between a gap and a result
That distance is where governance lives. A useful account separates four stages that are too easily collapsed into one: what the assessment records; which competent local authority decides what to do; who carries out and resources the decision; and what a later review observes. Each stage has its own actor, authority and evidence.
Consider a generic finding that responsibilities across institutions are unclear. The assessment may reveal the ambiguity. It does not decide which ministry or institution owns the response. A recommendation may suggest coordination, but the responsible authority still needs to select a feasible change, assign a lead, set a date and make resources available. Later, someone must check whether the new arrangement is being used and whether it addresses the original gap. These are governance questions, not technical instructions about laboratory practice.
Without that chain, two misleading stories are possible. First, the existence of a tool may be treated as proof of stronger oversight: capacity to assess is confused with capacity to act. Second, a list of planned activities may be presented as an outcome: an intention is confused with an observed change. Both overstate what the evidence supports and make it harder to learn which interventions work.
The question is not whether every local assessment should be published. WHO says the underlying data stay on local systems; that design can support local control over sensitive information. It also means outsiders should not assume there is a centralized, comparable dashboard. Public accountability can instead use a carefully chosen receipt: the issue category, the authorized owner, whether a decision was made, the broad action status, the next review date, and a privacy-screened description of what changed. It should not expose raw assessment answers or operational details that create avoidable risk.
A rollout is evidence of use, not proof of impact
WHO’s 29 September 2026 update describes several different forms of rollout. It says Uganda was among the early countries to apply the framework in 2024, and WHO’s 2025 pilot report covers work from August 2023 to July 2024. That report includes a survey of 36 organizations and recommendations. It is useful contextual evidence about one pilot; it is not a representative estimate of every Ugandan research institution, and it does not establish that BRIET caused a particular outcome.
The same WHO update says Malaysia began a whole-of-government pilot after an April 2026 workshop and that India was conducting institutional-level pilots with research institutions and laboratory networks. At that point, WHO expected both efforts to conclude by the end of 2026. A future target is not a completed milestone. The update also reported more than 1,000 enrollments in a WHO Academy course. Enrollment indicates reach, not demonstrated competence or changed institutional practice.
WHO says early implementation experience suggests that the framework is helping institutions identify gaps and strengthen coordination. That is an important signal from the organization running the work, and it should be attributed as such. The public material reviewed does not supply a counterfactual or independent evaluation demonstrating a reduction in risk. Keeping the distinction visible is not skepticism for its own sake. It preserves the ability to recognize success if later evidence supports it—and to see where additional action is needed if it does not.
The governance test is therefore modest but demanding: can an institution show how an assessment finding became a local decision, how a person or office was made responsible, whether the chosen response was resourced, and what a later review found? The answer can be public without making sensitive records public. It can also be negative or inconclusive. A measure that only permits good news is not a learning system.
Sources
- WHO: tools to govern life sciences and dual-use research, 29 September 2026
- WHO launches BRIET, 28 August 2026
- WHO Global guidance framework for the responsible use of the life sciences
- WHO: piloting the Global guidance framework
- WHO programme on responsible use of life-sciences research
- BRIET public entry point
- WHO launches guide to safely unlock benefits of life sciences, 13 September 2022
- WHO Technical Advisory Group material on responsible use of life sciences
Member Briefing
Deeper Profile Context
Sign in with the right membership level to unlock the full briefing and source notes.
Only for Strategic Circle
Strategic Circle
Open to all readers. Unlock profile briefings after joining and signing in.
Join Strategic CircleOnly for Leadership Alliance
Leadership Alliance
For qualified IP-asset owners and management; sign in to unlock alliance briefings.
Join Leadership Alliance
